Oncology Times - Ot Broadcasts From The Ipad Archives
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 30:26:30
- Mais informações
Informações:
Sinopse
Independent and targeted hematology/oncology news for cancer patient care team; breaking clinical news; oncology analysis and commentary; professional trends.
Episódios
-
10th European Congress on Perspectives in Lung Cancer, Brussels
21/07/2009 Duração: 07minSilvia Novello and Giorgio Scagliotti on harnessing insulin-like growth factor receptor inhibition in a Phase II study that showed clinical activity of figitumumab to be at least as good as that of inhibitors of other growth factors already being used in cancer.
-
Bilateral Prophylactic Mastectomy for DCIS
21/07/2009 Duração: 10minTodd Tuttle from University of Minnesota & Abram Recht from Beth Israel Deaconess Medical Center on the surprisingly big recent increase in the use of prophylactic bilateral mastectomy for DCIS.
-
Cancer-Related Fatigue
21/07/2009 Duração: 12minPaddy Stone of St. George's Hospital, University of London, & David Cella from Northwestern University Feinberg School of Medicine about the effective use of questionnaires for assessing, screening, and perhaps diagnosing cancer-related fatigue syndrome.
-
The Smartest Oncologist in the World? – Well, at least in the US!
21/07/2009 Duração: 06minStanley H. Winokur, MD, on his clever, fun, and ever-evolving one-minute daily Internet quiz that lets oncologists test their knowledge & compete against others. TheSmartestOncologist.com
-
Breast Cancer: St. Gallen Meeting Endorses Multi-Gene Assays for Refining Chemo Decision
21/07/2009 Duração: 07minAlso from the Palm Beach Cancer Symposium, Kathy Albain, MD, talks about the St. Gallen consensus meeting’s updated recommendations about adjuvant therapy for breast cancer—i.e., endorsing the 21-gene recurrence score and 70-gene profiling assay as key tools in decision-making for chemotherapy for ER-positive disease.
-
Oropharyngeal Cancer: Better Outlook with HPV-Directed Therapies
21/07/2009 Duração: 06minMarshall Posner, MD, talking from Palm Beach Cancer Symposium: Increased prevalence of HPV-related oropharyngeal cancers, more responsive to treatment with induction docetaxel, cisplatin, & 5-FU prior to standard chemoradiotherapy.
-
CML: Hagop Kantarjian on Treating Patients with the T315I Mutation
21/07/2009 Duração: 09minAlso: (1) Feasibility of patients becoming pregnant while having TKI treatment after having stable disease for at least two years; and (2) Decreased need for allogeneic transplant.
-
KRAS-Driven Selection of Molecular Therapy for Metastatic Colorectal Cancer: Choosing Between Bevacizumab, Cetuximab, Panitumomab, or a Combination
21/07/2009 Duração: 03minInterviewed at the Palm Beach Cancer Symposium, John Macdonald, Chief Medical Officer of Aptium Oncology in Los Angeles, talks about his latest data on the relevance of KRAS tumor status—i.e., whether the gene is wild-type or mutant determines the sensitivity of the tumor to anti-EGF or anti-VEGF receptor therapy. He also discusses the disappointing finding that blocking both of these proliferation pathways does not lead to improved efficacy when two targeted drugs are used in combination.